Back to top
more

Option Care Health (OPCH)

(Delayed Data from NSDQ)

$29.61 USD

29.61
1,759,663

+0.32 (1.09%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $29.61 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Option Care (OPCH) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Investors Undervaluing Option Care Health (OPCH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Option Care (OPCH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 10.34% and 2.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Debanjana Dey headshot

4 Stocks to Watch in a Resilient Outpatient Home Health Industry

by Debanjana Dey

The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.

Sumit Singh headshot

These 4 Stocks Boast Impressive Interest Coverage Ratio

by Sumit Singh

A company capable of generating earnings well above its interest expense can withstand financial hardship. LRN, MOD, AMZN and OPCH are in a strong enough position to meet financial obligations.

Sumit Singh headshot

Pick These 4 Stocks With Amazing Interest Coverage Ratio

by Sumit Singh

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOH, ATO, AMZN and OPCH are sound enough to meet financial obligations.

Zacks Industry Outlook Highlights DaVita, Option Care Health, Addus HomeCare and Pennant

by Zacks Equity Research

DaVita, Option Care Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.

Debanjana Dey headshot

4 Stocks to Watch in an Evolving Outpatient Home Health Industry

by Debanjana Dey

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.

Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 6.90% and 0.07%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.37% and 1.66%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Option Care Health (OPCH) in Q3 Earnings?

by Zacks Equity Research

Option Care Health's (OPCH) Q3 results are likely to be driven by sustained strong utilization.

OPCH or CHE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

OPCH vs. CHE: Which Stock Is the Better Value Option?

Zacks.com featured highlights Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health

by Zacks Equity Research

Arcos Dorados Holdings, Karat Packaging, The Andersons and Option Care Health have been highlighted in this Screen of The Week article.

Ethan Feller headshot

2 Top Ranked Stocks with Sky High Earnings Growth Forecasts

by Ethan Feller

Earnings growth is a leading indicator of a company's financial health and its potential for future stock price appreciation

Anirudha Bhagat headshot

Pick These 4 Solid Net Profit Margin Stocks for Solid Returns

by Anirudha Bhagat

Here we present four top-ranked stocks, ARCO, KRT, ANDE and OPCH, with solid net profit margins that can contribute toward making a strong portfolio.

Shaun Pruitt headshot

Top Medical Stocks to Buy Amid Market Volatility

by Shaun Pruitt

While there is no guarantee that medical stocks will offer a hedge against market volatility, healthcare is essential even during economic uncertainty.

Best Growth Stocks to Buy for September 27th

by Zacks Equity Research

AMWD, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 27, 2023.

Best Growth Stocks to Buy for September 19th

by Zacks Equity Research

JOB, OPCH and SPLK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 19, 2023.

Recent Price Trend in Option Care (OPCH) is Your Friend, Here's Why

by Zacks Equity Research

Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Philips (PHG) Expands Mobile C-arm Portfolio With Zenition 30

by Zacks Equity Research

Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.

Best Growth Stocks to Buy for September 15th

by Zacks Equity Research

FOUR, OPCH and JOB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15, 2023.